Zimmer Biomet Holdings EMEA — Goodwill Impaired Accumulated Impairment Loss remained flat by 0.0% to $1.33B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase signals past operational underperformance or overpayment for acquisitions in the EMEA region.
The cumulative total of all impairment charges recognized against the goodwill balance of the EMEA segment. This reflect...
Commonly tracked by peers to assess the long-term success of regional acquisition strategies.
zbh_segment_emea_goodwill_impaired_accumulated_impairment_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.04B | $1.04B | $1.04B | $1.33B | $1.33B | $1.33B | $1.33B | $1.33B | $1.33B | $1.33B |
| QoQ Change | — | +0.0% | +0.0% | +27.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +27.9% | +0.0% | +0.0% | — | — | +0.0% | — |